Kinase Gene Expression and Subcellular Protein Expression Pattern of Protein Kinase C Isoforms in Curcumin-treated Human Hepatocellular Carcinoma Hep 3B Cells
Curcumin, a yellow component of turmeric or curry powder, has been demonstrated to exhibit anti-carcinogenic effects in vitro, in vivo, and in human clinical trials. One of its molecular targets is protein kinase C (PKC) which has been reported to play essential roles in apoptosis, cell proliferation, and carcinogenesis. In this study, PKC mRNA expression was significantly inhibited in curcumin-treated human hepatocellular carcinoma (HCC) Hep 3B cells identified using a kinase cDNA microarray. Furthermore, curcumin decreased total protein expression of all PKCs in a time-related manner by immunoblotting of whole cell lysates, nuclear, membrane, and cytosolic fractions. In cytosolic fraction, the expression of PKC-α was totally inhibited by curcumin. In contrast, the expression levels of PKC-ζ and -μ were dramatically increased. Increases in expression of PKC-δ and PKC-ζ in the membrane and nucleus, and PKC-ι in the membrane were detected. In summary, the changes in expression and distribution of subcellular PKC isoforms in curcumin-treated Hep 3B cells suggest possible PKC-associated anti-tumor mechanisms of curcumin and provide alternative therapies for human HCC.
KeywordscDNA microarray Curcumin Hepatocellular carcinoma Isoforms Protein kinase C
This study was supported by grants from the National Science Council, Taiwan (NSC 93-2320-B-309-002 and NSC 98-2313-B-003-002-MY3), Ministry of Economic Affairs, Taiwan (99-EC-17-A-17-S1-152), and National Taiwan Normal University, Taiwan (No. 99-D).
- 1.Bengmark S, Mesa MD, Gil A (2009) Plant-derived health: The effects of turmeric and curcuminoids. Nutr Hosp 24:273–281Google Scholar
- 8.Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390CrossRefGoogle Scholar
- 15.Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J (2003) TM4: A free, open-source system for microarray data management and analysis. Biotechniques 34:374–378Google Scholar
- 22.Hsu SL, Chou YH, Yin SC, Liu JY (1998) Differential effects of phorbol ester on growth and protein kinase C isoenzyme regulation in human hepatoma Hep 3B cells. Biochem J 333(Pt 1):57–64Google Scholar
- 23.Zhu BH, Yao ZX, Luo SJ, Jiang LM, Xiao JW, Liu SC, Liu JB, Sun JM, Pei ZY (2005) Effects of antisense oligonucleotides of PKC-alpha on proliferation and apoptosis of Hep G2 in vitro. Hepatobiliary Pancreat Dis Int 4:75–79Google Scholar
- 31.Nakajima T (2006) Signaling cascades in radiation-induced apoptosis: Roles of protein kinase C in the apoptosis regulation. Med Sci Monit 12:RA220–RA224Google Scholar
- 34.Selbie LA, Schmitz-Peiffer C, Sheng Y, Biden TJ (1993) Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem 268:24296–24302Google Scholar
- 39.Vantus T, Vertommen D, Saelens X, Rykx A, De Kimpe L, Vancauwenbergh S, Mikhalap S, Waelkens E, Keri G, Seufferlein T, Vandenabeele P, Rider MH, Vandenheede JR, Van Lint J (2004) Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: Identification of two cleavage sites by microsequencing. Cell Signal 16:703–709CrossRefGoogle Scholar